Cellulite Clinical Trial
Official title:
A Study Evaluating the Efficacy of Cell-u-Light Apparel in Enhancing Lymph Drainage and Improving the Appearance of Grades of Cellulite in Affected Participants
This trial is arranged in 3 stages, lasting 8 weeks overall, designed to assess the before, during and after effects of the low-compression apparel with its integrated, variably raised, ink-polymer pads. The study will recruit 21 (otherwise healthy) participants who are affected by cellulite. Volunteers will be selected in order to equally fill the 3 different grades of cellulite (7 volunteers of each grade (1, 2 & 3) - as Grade 0 is no evidence of cellulite, this category need not be included). Each volunteer will be 'sized' according to standard apparel sizing charts (as used by the manufacturer of the cycle shorts); Small (S), Medium (M), Large (L) and Extra Large (XL). All participants will follow the same 3 stage sequence, which will involve a total of 9 short visits to The Whiteley Clinic, each lasting approximately 30 minutes. Upon completion of these visits, participants will each be offered £90 to subsidise their cost of travel - they will also be permitted to keep the low-compression apparel following the study. During each appointment, several measurements and assessment will be made: - Standard demographics, weight, height, and any changes to dietary or exercise regimens over the trial period. - Subjective assessment of the cellulite by the participant. - Objective assessment and grading using the grading system described by Nunberger and Muller by the investigators - Images of their cellulite-affected areas will be taken (this may include an area over the buttocks and an area over the thighs), using a high-resolution medical imaging (camera) system (Vectra H2 (https://www.canfieldsci.com/imaging-systems/vectra-h2-3d-imaging-system/)), to be independently assessed by Canfield Consultants and to be graded by a 'panel' of clinicians for objective classifications. - Assessment of local lymphatic collections in the skin using a handheld lymph scanner to assess lymph accumulation (Delfin Lymphscanner, Delfin Technologies Ltd https://hadhealth.com/lymphscanner). - During stage 2 only, participant assessment as to ease of donning and doffing the product, and comfort of wearing it.
Status | Recruiting |
Enrollment | 24 |
Est. completion date | April 3, 2023 |
Est. primary completion date | April 3, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Affected by stages 1, 2 or 3 of cellulite - Can be placed into one of the sizes of the apparel (S, M, L, or XL) - Have had no recent abdominal/leg surgery - Are physically able to apply and remove low-compression apparel safely Exclusion Criteria: - Those on any special diets/medications that may affect weight especially hormone treatments that are changing such as IVF cycles - Any malignancy that is being actively investigated or treated - Any medical condition that is being actively investigated or treated - Anyone who is on special diets for weight loss or other health issues, with the exception of those on stable diets such a gluten free for coeliac. - Previous DVT - (Unusual/abnormal) leg swelling - Those who have had abdominal/leg operations within 1 year - Those who are not mobile - Those who are pregnant or planning to get pregnant |
Country | Name | City | State |
---|---|---|---|
United Kingdom | The Whiteley Clinic | Guildford |
Lead Sponsor | Collaborator |
---|---|
The Whiteley Clinic | Canfield |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To calculate the volume of dimpling from the 3D scanner | Use this to objectively determine whether there is a change in appearance of cellulite with compression | 9 weeks | |
Secondary | Using a visual analogue score for the participants and two blinded observers to score the appearance of cellulite from 0 to 10, 0 being the worst, 10 being the best to statistically analyse whether the opinion of cellulite has changed | Allows for statistical analysis between scores to see if there is a significant difference between the two. | 9 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03550157 -
Structural Changes of Subcutaneous Tissue by Ultrasonographies in Patients After Treatment With PnKCelulitis® Program
|
||
Completed |
NCT03078647 -
Profound Dermal and SubQ Cartridges for the Treatment of Cellulite
|
N/A | |
Suspended |
NCT05441917 -
Phototherapy and Radiofrecuency for Cellulite
|
N/A | |
Completed |
NCT02942160 -
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
|
Phase 2 | |
Active, not recruiting |
NCT02489994 -
Performance of the ePrime System for Cellulite
|
N/A | |
Completed |
NCT01209767 -
Cryolipolysis and Subcision for Treatment of Cellulite
|
N/A | |
Completed |
NCT01702259 -
Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.
|
N/A | |
Completed |
NCT04580303 -
CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques
|
Phase 2 | |
Completed |
NCT05358847 -
Treatment for Cellulite Appearance
|
N/A | |
Terminated |
NCT04209530 -
Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women
|
Phase 2 | |
Completed |
NCT05064761 -
Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite
|
N/A | |
Completed |
NCT03329989 -
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
|
Phase 2 | |
Completed |
NCT04170296 -
Real World CCH Study in Adult Females With Cellulite
|
Phase 3 | |
Completed |
NCT04419454 -
Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite
|
||
Completed |
NCT05199506 -
Study to Evaluate the Safety and Effectiveness of the RAP Device for the Improvement in the Appearance of Cellulite
|
N/A | |
Completed |
NCT05836779 -
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)
|
Phase 2 | |
Completed |
NCT05026216 -
To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite.
|
Phase 4 | |
Completed |
NCT00399854 -
Evaluation of the Efficacy of Endermologie in Treatment of Cellulite and Body Contouring
|
Phase 4 | |
Completed |
NCT00947414 -
Cellulite and Extracorporeal Shock Wave
|
N/A | |
Completed |
NCT05419505 -
Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks
|
Phase 2 |